Exfoliated colonocyte DNA levels and clinical features in the diagnosis of colorectal cancer: A cohort study in patients referred for investigation

Colorectal Disease

Volumn 14, Issue 3, 2012, Pages 306-313

  Mahadavan, Lalitha ^a,b   Loktionov, Alexandre ^c   Daniels, Ian R ^a,c   Shore, Angela ^b   Cotter, Diane ^a   Llewelyn, Andrew H ^c   Hamilton, William ^b  

^a ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c Babraham Research Campus   (United Kingdom)

Author keywords

Colorectal cancer; Diagnosis; Proctoscopy

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FERRITIN; HEMOGLOBIN;

ARTICLE; CANCER DIAGNOSIS; CELL ISOLATION; CELL VOLUME; COLORECTAL CANCER; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; HUMAN; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; PROCTOSCOPE; RECEIVER OPERATING CHARACTERISTIC; RECTUM HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLON; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMANS; INTESTINAL MUCOSA; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCTOSCOPY; RECTUM; ROC CURVE;

EID: 84856759071     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02615.x     Document Type: Article

References (34)

1. Office for National Statistics (2009) MB1 No 37 - Cancer Registration Statistics 2006. Cancer Statistics: Registrations Series MB1. ONS, London.
2. Verdecchia A, Francisci S, Brenner H et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 784-96.
3. Berrino F, Verdecchia A, Lutz JM, Lombardo C, Micheli A, Capocaccia R. Comparative cancer survival information in Europe. Eur J Cancer 2009; 45: 901-8.
4. Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 2009; 101(S2): S115-24.
5. Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer 2009; 101(S2): S125-9.
6. Barrett J, Jiwa M, Rose P, Hamilton W. Pathways to the diagnosis of colorectal cancer: an observational study in three UK cities. Fam Pract 2006; 23: 15-9.
7. Goodyear S, Stallard N, Gaunt A, Parker R, Williams N, Wong LS. Local impact of the English arm of the UK Bowel Cancer Screening Pilot study. Br J Surg 2008; 95(9): 1172-9.
8. NICE. (2005) Referral Guidelines for Suspected Cancer. NICE, London.
9. Hamilton W, Sharp D. Diagnosis of colorectal cancer in primary care: the evidence base for guidelines. Fam Pract 2004; 21: 99-106.
10. Ford AC, Veldhuyzen van Zanten SJO, Rodgers CC, Talley NJ, Vakil N, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut 2008; 57: 1545-53.
11. Jellema P, van der Windt DAWM, Bruinvels DJ et al. Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ 2010; 340: c1269.
12. Hamilton W. Five misconceptions in cancer diagnosis. Br J Gen Pract 2009; 59: 441-7.
13. Neal R, Allgar V. Socio-demographic factors and delays in the diagnosis of six cancers: analysis of data from the 'National Survey of NHS Patients: Cancer'. Br J Cancer 2005; 92: 1971-5.
14. Jones R, Rubin G, Hungin P. Is the two week rule for cancer referrals working? BMJ 2001; 322: 1555-6.
15. Hamilton W, Round A, Sharp D, Peters T. Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Br J Cancer 2005; 93: 399-405.
16. Rai S, Kelly MJ. Prioritization of colorectal referrals: a review of the 2-week wait referral system. Colorectal Dis 2007; 9: 195-202.
17. Hamilton W, Lancashire R, Sharp D, Peters T, Cheng K, Marshall T. The risk of colorectal cancer with symptoms at different ages and between the sexes: a case-control study. BMC Med 2009; 7: 17.
18. Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng K, Marshall T. The importance of anaemia in diagnosing colorectal cancer: a case-control study using electronic primary care records. Br J Cancer 2008; 98: 323-7.
19. Weller D, Coleman D, Robertson R et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007; 97: 1601-5.
20. Khan N, NCRI Colorectal Clinical Studies Group. Implementation of a diagnostic tool for symptomatic colorectal cancer in primary care: a feasibility study. Primary Health Care Res Dev 2009; 10: 54-64. doi:.
21. Selvachandran S, Hodder R, Ballal M, Jones P, Cade D. Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet 2002; 360: 278-83.
22. Ballal MS, Selvachandran SN, Maw A. Use of a patient consultation questionnaire and weighted numerical scoring system for the prediction of colorectal cancer and other colorectal pathology in symptomatic patients: a prospective cohort validation study of a Welsh population. Colorectal Dis 2010; 12: 407-14.
23. Kelly MJ. Commentary: use of the WNS patient questionnaire. Colorectal Dis 2010; 12: 414-5.
24. Loktionov A. Cell exfoliation in the human colon: myth, reality and implications for colorectal cancer screening. Int J Cancer 2007; 120: 2281-9.
25. Loktionov A, Bandaletova T, Llewelyn A et al. Colorectal cancer detection by measuring DNA from exfoliated colonocytes obtained by direct contact with rectal mucosa. Int J Oncol 2009; 34: 301-12.
26. Loktionov A, Ferrett CG, Gibson JJS et al. A case-control study of colorectal cancer detection by quantification of DNA isolated from directly collected exfoliated colonocytes. Int J Cancer 2010; 126: 1910-9.
27. Sterne JAC, White IR, Carlin JB et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009; 338: b2393.
28. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28: 964-74.
29. StataCorp. (2008) Stata Statistical Software: Release 10. Stata Corporation, College Station, TX.
30. Zhou X-H, Obuchowski N, McClish D. (2002) Statistical Methods in Diagnostic Medicine. Wiley, New York.
31. Harrison W, Teale A, Jones S, Mohammed M. The impact of the introduction of liquid based cytology on the variation in the proportion of inadequate samples between GP practices. BMC Public Health 2007; 7: 191.
32. Stapley S, Peters TJ, Sharp D, Hamilton W. The mortality of colorectal cancer in relation to the initial symptom and to the duration of symptoms: a cohort study in primary care. Br J Cancer 2006; 95: 1321-5.
33. Department of Health (2009) Cancer Reform Strategy. Achieving local implementation - second annual report. pp. 81. Department of Health, London.
34. York Health Economics Consortium. (2007) Bowel Cancer Services: Costs and Benefits. Department of Health, London.